Here are the 10-K annual reports from Electromed, Inc. (ELMD) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow ELMD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ELMD filings page.
Electromed, Inc. (ELMD) develops and sells the SmartVest high frequency chest wall oscillation systems for airway clearance, primarily to U.S. homecare patients with bronchiectasis, COPD overlap, cystic fibrosis and neuromuscular conditions, using a direct-to-patient and provider model that captures both manufacturer and distributor margins.
For the year ended June 30, 2026, net revenues were $73.8 million, up 15.3% from 2025, led by 16.3% homecare growth. Gross profit was $57.9 million with a 78.5% gross margin. Operating income rose to $13.9 million, and net income increased 49.9% to $11.3 million, or $1.30 diluted EPS. R&D spending was $1.3 million, focused on product enhancements and clinical evidence.
Electromed ended 2026 with $20.5 million in cash, no borrowings on a $10 million revolving credit facility, and total shareholders’ equity of $54.0 million. The company repurchased 151,911 shares in fiscal 2026 and estimates HFCWO penetration of roughly 16% among about one million diagnosed U.S. bronchiectasis patients, highlighting a large underpenetrated market, while remaining heavily dependent on Medicare, Medicaid and private payer reimbursement.
Electromed, Inc. reported details in its Form 10-K that describe its business, capital structure and selected balance sheet and operating items. The company had 8,349,176 shares issued and outstanding as of June 30, 2025, down from 8,637,883 a year earlier after share repurchase programs that retired 280,017 and 220,899 shares in prior authorizations for total costs of $5,000,000 each and are now exhausted. The company maintains a $2.5 million secured line of credit with interest at prime less 1.0% (prime was 7.50% at June 30, 2025). Operating lease liabilities increased to $198,000 from $87,000 and related right-of-use assets and lease terms are disclosed. As of June 30, 2025, unrecognized compensation expense related to non-vested awards was $1,351,000 expected to be recognized over weighted-average periods near two years. The effective tax rates were 26.7% and 26.8% for fiscal 2025 and 2024. The Audit Committee and Board provide oversight of a cybersecurity risk management program co-led by senior management and third-party providers.